425: Strive CRO Reposts Merger Update with Semler Scientific

Strive's Chief Risk Officer reposted a communication on X.com regarding the proposed business combination with Semler Scientific, highlighting forward-looking statements and associated risks.

Summary

• A communication was reposted on X.com by Jeff Walton, Chief Risk Officer of Strive, Inc., on December 30, 2025.
• The communication pertains to Strive's proposed business combination with Semler Scientific, Inc.
• It includes cautionary statements regarding forward-looking statements about the transaction's outlook, strategic and financial benefits, timing, and the ability to successfully integrate the combined businesses.
• The filing outlines various risks, including potential termination of the merger agreement, failure to close, legal proceedings, and the possibility that anticipated benefits (including those from Bitcoin treasury strategies) may not be realized.
• Investors are urged to read the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus for comprehensive information about the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is neutral in tone, primarily serving as a cautionary and informational notice about a proposed merger. It outlines potential benefits as forward-looking statements but heavily emphasizes numerous risks, balancing any positive implications with significant uncertainties.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

Forward-looking statements indicate expectations for strategic and financial benefits from the proposed transaction, including the impact on the combined company's future financial performance and successful integration of businesses. However, these are subject to significant risks and uncertainties that could cause actual results to differ materially.

Management Comments

• Strive and Semler Scientific believe that their expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of their existing knowledge of their business and operations.

Industry Context

This filing is a standard procedural communication related to a proposed merger, common in the financial or healthcare technology sectors. The explicit mention of risks related to Bitcoin treasury strategies and other digital assets highlights the increasing integration of cryptocurrency-related activities into traditional corporate finance and the associated regulatory and market uncertainties.

Legal Proceedings

• Potential legal proceedings that may be instituted against Strive or Semler Scientific or the combined company related to the proposed transaction.

Stakeholder Impact

• Shareholders of Strive face potential dilution due to the issuance of additional Class A common stock.
• Shareholders of Semler Scientific will need to make a voting decision regarding the proposed transaction.
• Customers and employees of both companies may experience adverse reactions or changes to their relationships as a result of the merger announcement or completion.

Next Steps

• Strive and Semler Scientific will continue to work towards the closing of the proposed transaction.
• Semler Scientific stockholders are expected to vote on the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus, along with any amendments or supplements, for important information.

Key Dates

Recommendation

This filing is a procedural communication regarding a proposed merger, emphasizing forward-looking statements and a comprehensive list of risks. It does not provide new financial results or operational updates that would warrant a strong buy or sell recommendation. Investors should hold and conduct further due diligence on the detailed merger terms, financial projections, and integration plans outlined in the referenced S-4 and proxy statements before making definitive investment decisions. The significant risks, including potential dilution and integration challenges, suggest caution.

Keywords

Strive Inc., Semler Scientific Inc., Merger, Acquisition, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Bitcoin Treasury, Digital Assets, Corporate Governance